Julie L. Gerberding - Net Worth and Insider Trading

Julie L. Gerberding Net Worth

The estimated net worth of Julie L. Gerberding is at least $6 Million dollars as of 2024-04-27. Julie L. Gerberding is the EVP, Chief Patient Officer of Merck & Co Inc and owns about 39,162 shares of Merck & Co Inc (MRK) stock worth over $5 Million. Julie L. Gerberding is also the Director of Cerner Corp and owns about 8,128 shares of Cerner Corp (CERN) stock worth over $771,510. Details can be seen in Julie L. Gerberding's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Julie L. Gerberding has not made any transactions after 2021-11-01 and currently still holds the listed stock(s).

Transaction Summary of Julie L. Gerberding

Julie L. Gerberding Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Julie L. Gerberding owns 5 companies in total, including Merck & Co Inc (MRK) , Cerner Corp (CERN) , and AfterNext HealthTech Acquisition Corp (AFTR) among others .

Click here to see the complete history of Julie L. Gerberding’s form 4 insider trades.

Insider Ownership Summary of Julie L. Gerberding

Ticker	Comapny	Transaction Date	Type of Owner
MRK	Merck & Co Inc	2021-11-01	EVP Strat Comm & GI Pub Policy
CERN	Cerner Corp	2019-08-22	director
AFTR	AfterNext HealthTech Acquisition Corp	2021-08-11	director
HLVX	HilleVax Inc	2022-04-28	director
MRKPRB.PFD	Merck & Co Inc	2019-05-03	EVP Strat Comm & GI Pub Policy

Julie L. Gerberding Latest Holdings Summary

Julie L. Gerberding currently owns a total of 2 stocks. Among these stocks, Julie L. Gerberding owns 39,162 shares of Merck & Co Inc (MRK) as of November 1, 2021, with a value of $5 Million and a weighting of 86.94%. Julie L. Gerberding also owns 8,128 shares of Cerner Corp (CERN) as of August 22, 2019, with a value of $771,510 and a weighting of 13.06%.

Latest Holdings of Julie L. Gerberding

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
MRK	Merck & Co Inc	2021-11-01	39,162	131.20	5,138,054
CERN	Cerner Corp	2019-08-22	8,128	94.92	771,510

Holding Weightings of Julie L. Gerberding

Julie L. Gerberding Form 4 Trading Tracker

According to the SEC Form 4 filings, Julie L. Gerberding has made a total of 3 transactions in Merck & Co Inc (MRK) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Merck & Co Inc is the sale of 96,270 shares on November 1, 2021, which brought Julie L. Gerberding around $8 Million.

According to the SEC Form 4 filings, Julie L. Gerberding has made a total of 1 transactions in Cerner Corp (CERN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Cerner Corp is the sale of 7,928 shares on August 22, 2019, which brought Julie L. Gerberding around $569,389.

Insider Trading History of Julie L. Gerberding

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Julie L. Gerberding Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Julie L. Gerberding Ownership Network

Ownership Network List of Julie L. Gerberding

No Data

Ownership Network Relation of Julie L. Gerberding

Julie L. Gerberding Owned Company Details

What does Merck & Co Inc do?

Who are the key executives at Merck & Co Inc?

Julie L. Gerberding is the EVP Strat Comm & GI Pub Policy of Merck & Co Inc. Other key executives at Merck & Co Inc include EVP & CFO Caroline Litchfield , Evp & Global Svcs & CFO Robert M Davis , and President & Human Health Int?l Joseph Romanelli .

Merck & Co Inc (MRK) Insider Trades Summary

Over the past 18 months, Julie L. Gerberding made no insider transaction in Merck & Co Inc (MRK). Other recent insider transactions involving Merck & Co Inc (MRK) include a net sale of 133,401 shares made by Steven Mizell , a net sale of 72,029 shares made by Johannes Jacobus Oosthuizen , and a net sale of 5,715 shares made by Joseph Romanelli .

In summary, during the past 3 months, insiders sold 309,424 shares of Merck & Co Inc (MRK) in total and bought 0 shares, with a net sale of 309,424 shares. During the past 18 months, 3,968,347 shares of Merck & Co Inc (MRK) were sold and 409 shares were bought by its insiders, resulting in a net sale of 3,967,938 shares.

Merck & Co Inc (MRK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Merck & Co Inc Insider Transactions

No Available Data

What does Cerner Corp do?

Who are the key executives at Cerner Corp?

Julie L. Gerberding is the director of Cerner Corp. Other key executives at Cerner Corp include VP & Chief Accounting Officer Michael R. Battaglioli , Chief Human Resources Officer Tracy L Platt , and EVP & Chief Health Officer Nasim Afsarmanesh .

Cerner Corp (CERN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cerner Corp (CERN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cerner Corp (CERN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cerner Corp (CERN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cerner Corp Insider Transactions

No Available Data

What does AfterNext HealthTech Acquisition Corp do?

Who are the key executives at AfterNext HealthTech Acquisition Corp?

Julie L. Gerberding is the director of AfterNext HealthTech Acquisition Corp. Other key executives at AfterNext HealthTech Acquisition Corp include director & 10 percent owner Jon Winkelried , director & 10 percent owner Tpg Gp A, Llc , and director & Chief Executive Officer R Halsey Wise .

AfterNext HealthTech Acquisition Corp (AFTR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AfterNext HealthTech Acquisition Corp (AFTR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AfterNext HealthTech Acquisition Corp (AFTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AfterNext HealthTech Acquisition Corp (AFTR)'s detailed insider trading history can be found in Insider Trading Tracker table.

AfterNext HealthTech Acquisition Corp Insider Transactions

No Available Data

What does HilleVax Inc do?

Who are the key executives at HilleVax Inc?

Julie L. Gerberding is the director of HilleVax Inc. Other key executives at HilleVax Inc include director & Chief Operating Officer Aditya Kohli , 10 percent owner Frazier Life Sciences X, L.p. , and director & President and CEO Robert Hershberg .

HilleVax Inc (HLVX) Insider Trades Summary

Over the past 18 months, Julie L. Gerberding made no insider transaction in HilleVax Inc (HLVX). Other recent insider transactions involving HilleVax Inc (HLVX) include a net sale of 86,866 shares made by Aditya Kohli , a net sale of 48,933 shares made by Astrid Borkowski , and a net sale of 11,597 shares made by Robert Hershberg .

In summary, during the past 3 months, insiders sold 105,972 shares of HilleVax Inc (HLVX) in total and bought 10,100 shares, with a net sale of 95,872 shares. During the past 18 months, 150,972 shares of HilleVax Inc (HLVX) were sold and 10,100 shares were bought by its insiders, resulting in a net sale of 140,872 shares.

HilleVax Inc (HLVX)'s detailed insider trading history can be found in Insider Trading Tracker table.

HilleVax Inc Insider Transactions

No Available Data

What does Merck & Co Inc do?

Who are the key executives at Merck & Co Inc?

Julie L. Gerberding is the EVP Strat Comm & GI Pub Policy of Merck & Co Inc. Other key executives at Merck & Co Inc include President & Human Health Int?l Joseph Romanelli , Chief Marketing Officer Chirfi Guindo , and SVP & U.S. Market Johannes Jacobus Oosthuizen .

Merck & Co Inc (MRKPRB.PFD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Merck & Co Inc (MRKPRB.PFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Merck & Co Inc (MRKPRB.PFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Merck & Co Inc (MRKPRB.PFD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Merck & Co Inc Insider Transactions

No Available Data

Julie L. Gerberding Mailing Address

Above is the net worth, insider trading, and ownership report for Julie L. Gerberding. You might contact Julie L. Gerberding via mailing address: 2000 Galloping Hill Road, Kenilworth Nj 07033.

Discussions on Julie L. Gerberding

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.